Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7345 p451
16 April 2005

This article
Reprint   Photocopy

PDF 90K, Acrobat Reader

Letters

· General election
· EU services directive
· Repeat dispensing
· Community pharmacy
· New contract
· Charge refunds
· Technicians
· Antipsychotics
· Methadone
· The profession (2)
· Registration


Letters to the Editor

New contract

Contract 2005

Is it worth the candle?

From Mr A. J. T. Low, MRPharmS

The new community pharmacy contract presents opportunities and provides a framework on which further activities can be built. I do not doubt that in some pharmacies this may be accomplished but in most cases how are these extra activities going to be incorporated into a day when prescription volumes are on the increase?

Also of concern to me is something which appears under the guidelines for promotion of healthy lifestyles. We now need to record any “opportunistic advice” we give to patients on their medication records. Say we advise someone with type 2 diabetes to lose weight or advise someone on anti-hypertensive medication both to lose weight and to stop smoking. We now have to record this advice on the patient medication record. This takes time and so may influence how often and when we give advice. We may think twice now, especially at busy times, or we may just not bother at all, thinking the game is not worth the candle.

I know we have to be accountable to primary care trusts and provide evidence to PCT inspectors that we are doing our bit, but I think this measure may be counter-productive. It may mean we are even less likely to leave the dispensary to venture into dialogue with a patient or customer.

It may just further confine us to our dispensary role, which I suppose was going to happen with the increasing prescription traffic anyway. Would there ever be any chance that we could be paid for making this “opportunistic advice” to make it more worth our while?

Andrew Low
Harrow, Middlesex

Send your letter to The Editor

Previous Topic (Community pharmacy)
Next Topic (Charge refunds)

Back to Top


©The Pharmaceutical Journal